MedTrace Logo

Increased Microcirculation for Preventing Postoperative Wound Infections in Patients Undergoing Reduction Mammoplasty

NCT01538173 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 334

Last updated 2015-12-02

No results posted yet for this study

Summary

In this prospective study we investigated the impact of an improved postoperative microcirculation and its effect of surgical side infections after breast reduction.

Conditions

  • Surgical Side Infections After Breast Reduction

Interventions

DRUG

250ml HES 6%

Application twice a day 250ml HES 6% for three days postoperatively.

DRUG

9% NaCl 500ml

Application twice a day 500ml 9% NaCl for three days postoperatively.

Sponsors & Collaborators

  • University of Rostock

    collaborator OTHER

  • Max Dieterich

    lead OTHER

Principal Investigators

  • Max Dieterich, MD · University of Rostock

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2011-10-31
Completion
2012-02-29

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538173 on ClinicalTrials.gov